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ABSTRACT
Much attention has focussed on the conversion of human pluripotent
stem cells (PSCs) to a more naïve developmental status. Here we
provide a method for resetting via transient histone deacetylase
inhibition. The protocol is effective across multiple PSC lines and can
proceed without karyotype change. Reset cells can be expanded
without feeders with a doubling time of around 24 h. WNT inhibition
stabilises the resetting process. The transcriptome of reset cells
diverges markedly from that of primed PSCs and shares features with
human inner cell mass (ICM). Reset cells activate expression of
primate-specific transposable elements. DNA methylation is globally
reduced to a level equivalent to that in the ICM and is non-random,
with gain of methylation at specific loci. Methylation imprints are
mostly lost, however. Reset cells can be re-primed to undergo
tri-lineage differentiation and germline specification. In female reset
cells, appearance of biallelic X-linked gene transcription indicates
reactivation of the silenced X chromosome. On reconversion to
primed status, XIST-induced silencing restores monoallelic gene
expression. The facile and robust conversion routine with
accompanying data resources will enable widespread utilisation,
interrogation, and refinement of candidate naïve cells.
KEYWORDS: Pluripotent stem cells, Differentiation, Human embryo,
Methylome, Reprogramming
INTRODUCTION
Studies of the early mouse embryo and of derivative stem cell
cultures have led to the proposition that pluripotency proceeds
through at least two phases: naïve and primed (Hackett and Surani,
2014; Kalkan and Smith, 2014; Nichols and Smith, 2009, 2012;
Rossant and Tam, 2017). Recent reports provide evidence that the
naïve phase of pluripotency characterised in rodent embryos may be
present in a similar form in the early epiblast of primate embryos,
albeit with some species-specific features (Boroviak et al., 2015;
Nakamura et al., 2016; Reik and Kelsey, 2014; Roode et al., 2012;
Takashima et al., 2014). However, mouse embryonic stem cells
(ESCs) correspond to naïve pre-implantation epiblast (Boroviak
et al., 2014, 2015), whereas human pluripotent stem cell (hPSC)
cultures (Takahashi et al., 2007; Thomson et al., 1998; Yu et al.,
2007) seem to approximate primitive streak stage epiblast
(Davidson et al., 2015; Irie et al., 2015; Wu et al., 2015;
Nakamura et al., 2016). In general, hPSCs more closely resemble
mouse post-implantation epiblast-derived stem cells (EpiSCs)
(Brons et al., 2007; Tesar et al., 2007) than ESCs. Consequently,
they are considered to occupy the primed phase of pluripotency.
Mouse ESCs can be propagated as highly uniform populations that
exhibit consistent and unbiased multi-lineage differentiation in vitro
and in chimaeras (Martello and Smith, 2014; Wray et al., 2010; Ying
et al., 2008). These attributes contrast favourably with the
heterogeneity and variable differentiation propensities of primed
hPSCs (Butcher et al., 2016; Nishizawa et al., 2016) and have
provoked efforts to determine conditions that will support a human
naïve condition (De Los Angeles et al., 2012). Early studies lacked
stringent criteria for demonstrating a pluripotent identity with
comprehensive resemblance to both rodent ESCs and naïve cells in
the human embryo (Davidson et al., 2015; Huang et al., 2014).
However, two culture conditions have now been described for
sustaining reset hPSC phenotypes that exhibit a wide range of both
global and specific properties expected for naïve pluripotency
(Takashima et al., 2014; Theunissen et al., 2016, 2014).
Furthermore, candidate naïve hPSCs can be derived directly from
dissociated human inner cell mass (ICM) cells (Guo et al., 2016).
These developments support the contention that the core principle of
naïve pluripotency may be conserved between rodents and primates
(Nakamura et al., 2016; Nichols and Smith, 2012; Smith, 2017).
Nonetheless, current techniques for resetting conventional primed
hPSCs to a more naïve state raise issues concerning employment of
transgenes, universality, genetic integrity, and ease of use. Here, we
address these challenges and provide a simple protocol for consistent
resetting to a stable and well-characterised candidate naïve phenotype.
RESULTS
Transient histone deacetylase inhibition resets human
pluripotency
To monitor pluripotent status we exploited the piggyBac (PB)
EOS-C(3+)-GFP/puroR reporter (EOS) as previously described
(Takashima et al., 2014). Expression of this reporter is directed by
mouse regulatory elements that are active in undifferentiated ESCs:
a trimer of the CR4 element from the Oct4 (Pou5f1) distal enhancer
coupled with the early transposon (Etn) long terminal repeat
promoter (Hotta et al., 2009). We observed that conventional human
ESCs (hESCs) stably transfected with the piggyBac construct and
maintained in KSR/FGF on feeders quickly lost visible EOS-GFP,
although expression remained detectable by flow cytometry
(Fig. S1A,B). Expression was further diminished when cells were
transferred into 2iLIF (two inhibitors – the MEK inhibitor PD and
the GSK3 inhibitor CH – with the cytokine leukaemia inhibitoryReceived 12 November 2016; Accepted 9 June 2017
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factor LIF; see Materials and Methods) or MEK inhibitor plus LIF
(PDLIF) culture (Fig. S1C). By contrast, the PB-EOS reporter is
upregulated during transgene-induced resetting and visible
expression is maintained in naïve-like cells (Takashima et al.,
2014). These observations suggested that PB-EOS might be subject
to reversible epigenetic silencing in primed hPSCs.
Histone deacetylase (HDAC) inhibitors are global epigenetic
destabilisers that have been used to facilitate nuclear transfer (Ogura
et al., 2013), somatic cell reprogramming (Huangfu et al., 2008) and
mouse EpiSC resetting (Ware et al., 2009). We investigated whether
exposure to HDAC inhibitors would promote conversion of human
primed cells to a naïve state. We applied valproic acid (VPA) or
sodium butyrate to Shef6 hESCs carrying the PB-EOS reporter
(S6EOS cells). When cells were treated for 3 days in E6 medium
supplemented with PDLIF, then exchanged to t2iLGö naïve cell
maintenance medium, the EOS reporter was upregulated (Fig. 1A,B).
Bright GFP-positive colonies with dome-shapedmorphology emerged
over several days. We varied the culture parameters and empirically
determined conditions that consistently yielded EOS expression in
compact spheroid colonies (Fig. 1A-C). We tested the method on
H9EOS reporter cells and found that they similarly acquired bright
GFP expression and formed dome-shaped colonies (Fig. S1D).
We monitored the expression of OCT4, NANOG and the primate
naïve marker KLF17 (Guo et al., 2016) during resetting of S6EOS
cells. RT-qPCR analysis (Fig. 1D) shows that both OCT4 and
NANOG expression decrease without HDAC inhibitor treatment,
consistent with differentiation in PDLIF. By contrast, in HDAC
inhibitor-treated cells, OCT4mRNA levels show a transient increase
on day 3 then remain at a similar level to that in primed cells, whereas
NANOG transcripts increase ∼2-fold over the first 9 days. KLF17
transcripts are not detected in conventional hESCs, but become
appreciable from day 7 onwards during resetting. KLF17 protein
became apparent in some cells by immunofluorescence staining from
as early as day 3 of resetting (Fig. 1E).
Cultures were dissociated with TrypLE after 9 days of resetting
and replated in naïve culture medium, t2iLGö. Some differentiation
and cell death were evident, and a few passages were required before
the EOS-positive population became stable and predominant
(Fig. 1F, Fig. S1E,F). From passage 5 onwards the reset
phenotype was robust and could thereafter be expanded reliably.
The ability to enrich the naïve phenotype after resetting by bulk
passaging in t2iLGö suggested that a reporter should be dispensable,
facilitating general applicability. We therefore tested resetting
without the EOS transgene on a panel of primed human ESCs and
induced pluripotent stem cells (iPSCs). Stable cultures of compact
colonies displaying naïve marker gene expression were established
consistently (Table 1, Fig. 1G). These cell lines are denoted by the
designation cR (chemically reset). Resetting efficiency varied
between lines and according to initial culture status. In general,
however, a single well of a 6-well plate of primed PSCs was
sufficient for initial generation of multiple colonies and subsequent
establishment of stable naïve cultures by passage 5. Rho-associated
kinase (ROCK) inhibitor was used during resetting and initial
expansion in most experiments, but was usually omitted during
subsequent propagation. Together with NANOG, reset cells
expressed the naïve transcription factor proteins KLF4 and
TFCP2L1, which are present in the human ICM (Takashima
et al., 2014) but undetectable in primed PSCs (Fig. 1H).
Feeder-free expansion of reset cells
As noted previously (Takashima et al., 2014), reset cells can be
cultured on pre-coated plates without feeders. However, morphology
was heterogeneous, with more differentiation and cell death than on
feeders. We varied conditions and found that provision of growth
factor-reduced Geltrex with the culture medium at the time of plating
was more effective than pre-coating (Fig. 2A). Geltrex or laminin
applied in this manner supported continuous propagation in t2iLGö
of both embryo-derivedHNES and chemically reset cells, with robust
expression of naïve pluripotency factors (Fig. 2B-D). Moreover,
aberrant expression of some mesoendodermal genes was reduced in
feeder-free conditions (Fig. 2E).
In the absence of feeders we found that some reset cell lines
expanded more robustly in very low (0.3 µM) or even no CH
(Fig. 2F). This is in line with observations that GSK3 inhibition is
optional in the alternative 5i/L/A naïve culture system (Theunissen
et al., 2016). We subsequently adopted 0.3 µM CH for standard
culture. Naïve cell maintenance medium with 0.3 µM CH is termed
tt2iLGö. Reset cultures in Geltrex and tt2iLGö displayed
homogeneous morphology and expanded continuously with a
doubling rate of ∼24 h (Fig. 2G,H).
We also observed that omitting CH entirely for the first 10 days of
resetting increased the yield of EOS-positive cells. We therefore
implemented a revised resetting routine, omitting CH initially then
exchanging into tt2iLGö on feeders before transfer to Geltrex
culture. PSCs reset in these conditions showed consistent feeder-
free expansion, with typical naïve morphology, growth and marker
profiles that were indistinguishable from cells reset in the presence
of CH (Fig. 2I).
WNT inhibition stabilises resetting
As noted above, EOS-GFP-positive and KLF17-immunopositive
colonies emerged within 10 days of VPA treatment (Fig. 1E).
However, differentiation and cell death are ongoing for several
passages and during this period we observed that the reset
phenotype could not be sustained without feeders. Thus, the
resetting process appears incomplete and vulnerable at early stages.
We also noted a requirement for a stabilisation period following
doxycycline (DOX) withdrawal during transgene-mediated
resetting (Takashima et al., 2014). We used H9-NK2 cells, with
DOX-dependent expression of NANOG and KLF2, to explore
conditions that might stabilise resetting. We tested two candidates:
the amino acid L-proline and the tankyrase inhibitor XAV939
(XAV). L-proline is reported to be produced by feeders and to
alleviate nutrient stress in mouse ESCs (D’Aniello et al., 2015).
XAV inhibits canonical Wnt signalling (Huang et al., 2009) and has
previously been reported to facilitate the propagation of pluripotent
cells in alternative states (Kim et al., 2013; Zimmerlin et al., 2016).
Wewithdrew DOX from H9-NK2 cells and applied either L-proline
(1 mM) or XAV (2 µM) in combination with t2iLGö. We assessed
colony formation on feeders after the first and second passages. We
saw no pronounced effect of L-proline. By contrast, addition of
XAV resulted in more robust production of uniform domed colonies
(Fig. 3A). RT-qPCR analysis substantiated the presence of naïve
pluripotency markers in XAV-supplemented cultures and also
highlighted reduced levels of lineage-affiliated markers such as
brachyury (T) and GATA factors (Fig. 3B).
We investigated whether WNT inhibition would stabilise
emergent cR cells. In addition to the tankyrase inhibitor XAV, we
tested an orthogonal WNT pathway inhibitor, IWP2, which acts to
prevent the production of functional WNT protein (Chen et al.,
2009). XAVor IWP2 were added following VPA treatment on day 3
of resetting H9EOS and S6EOS cells (Fig. 3C). For both inhibitors
we observed reduced numbers of differentiating or dying cells and a
substantial increase in the frequency of EOS-GFP-positive cells by
2749
STEM CELLS AND REGENERATION Development (2017) 144, 2748-2763 doi:10.1242/dev.146811
D
E
V
E
LO
P
M
E
N
T
Fig. 1. Resetting human pluripotent stem cells (hPSCs) with HDAC inhibitors. (A) Schematic of the chemical resetting protocol. HDACi, HDAC inhibitor.
(B) Images of reset S6EOS cells at day 9 in t2iLGö. Red staining is from Gö6983. VPA, valproic acid; NaB, sodium butyrate. (C) Flow cytometry analysis of
EOS-GFP expression at day 9 of resetting. (D) RT-qPCR analysis of pluripotency markers in S6EOS cells subjected to the resetting culture regimewith or without
VPA. Error bars indicate s.d. of technical duplicates. (E) Immunostaining for OCT4 and KLF17 during resetting of Shef6 cells. (F) Images of reset S6EOS cultures
over the first four passages. (G) RT-qPCR analysis of general and naïve pluripotency markers in various reset cell cultures. Error bars indicate s.d. of technical
duplicates. (H) Immunostaining of pluripotency markers in established reset culture, cR-H9EOS. Scale bars: 100 μm.
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day 9, which increased further on passaging into tt2iLGö on MEFs
(Fig. 3D, Fig. S2A). After the second passage the majority of
colonies displayed domed morphology and readily visible GFP
(Fig. 3E). WNT inhibitor-treated H9EOS cultures at passage 2
expressed higher levels of naïve markers and lower GATA6 and
GATA3 than parallel cultures reset without WNT inhibition
(Fig. 3F). Similarly, S6EOS cells reset using XAV or IWP2
progressed to stable reset cultures expressing naïve markers and
minimal levels of brachyury, CDX2 and GATA6 (Fig. S2B). From
passage 3, we transferred XAV-treated cells to feeder-free culture in
tt2iLGö and Geltrex without XAV. Marker analysis by RT-qPCR
confirmed maintained expression of signature naïve pluripotency
factors after four passages at similar levels to those in reset cells
generated without the use of WNT inhibitors (Fig. 3G).
We also assessed whether vitamin C was required for resetting.
For the 3 day period of exposure to VPA we replaced E6 medium,
which contains vitamin C, with N2B27 medium with or without
addition of vitamin C. Resetting was continued in the presence of
XAV as above. After two passages we observed comparable
upregulation of EOS-GFP and similar expression of naïve markers
with or without exposure to vitamin C (Fig. S2C,D).
Collectively, these findings establish that, following VPA
treatment, WNT inhibition can improve the rate and efficiency of
conversion to a stable naïve phenotype that can subsequently be
propagated robustly in tt2iLGö with or without feeders or ongoing
WNT inhibition. The results also indicate that vitamin C
supplementation is not required for resetting. Full details of the
protocol and cell lines reset are provided in the supplemental
Materials and Methods and Table S1.
Global transcriptome profiling
We obtained transcriptome data by RNA sequencing (RNA-seq) of
replicate samples of reset cells generated by VPA treatment. We also
sequenced the embryo-derived naïve stem cell line HNES1 (Guo
et al., 2016) and a parallel culture of HNES1 cells that had been
ʻprimed’ by transfer into KSR/FGF for more than ten passages. We
added to the analysis published data (see Materials and Methods)
from cells reset with inducible transgenes (Takashima et al., 2014),
HNES cells cultured in the presence of vitamin C and ROCK
inhibitor (Guo et al., 2016), naïve-like cells in 5i/L/A (Ji et al., 2016)
and a variety of conventional PSCs from publicly available
resources and our own studies. We applied two complementary
dimensionality reduction techniques: principal component analysis
(PCA) identifies and ranks contributions of maximum variation in
the underlying dataset, whereas t-distributed stochastic neighbour
embedding (t-SNE) is a probabilistic method that minimises the
divergence between pairwise similarities in the constituent data
points. Both analyses of global transcriptomes unambiguously
discriminate naïve/reset samples from primed PSCs (Fig. 4A,B). In
each analysis, cR cells cluster closely together with HNES1 cells
that were cultured in parallel. Sample replicates are intermingled
despite being from cell lines of disparate provenance and culture
history. Feeder-free cultures form a slightly distinct cluster within
the naïve grouping. Consistent with previous analyses (Huang et al.,
2014; Irie et al., 2015; Nakamura et al., 2016; Takashima et al.,
2014; Theunissen et al., 2016), two independent RNA-seq datasets
for purported naïve cells cultured in 4i (NHSM) conditions (Gafni
et al., 2013; Irie et al., 2015; Sperber et al., 2015) cluster with
conventional primed PSCs by both PCA and t-SNE, as do cultures
in ʻextended pluripotency’media (Yang et al., 2017). For both naïve
and primed cells, PCA component 2 appears sensitive to differences
in growth conditions and/or batch effects and to capture variation
between laboratories and cell lines.
Gene Ontology (GO) analysis of genes contributing to PCA
component 1 shows significant enrichment of functional categories
primarily associated with extracellular matrix, development and
differentiation (Table S2), reflecting distinct identities associated
with naïve and primed cells. We also noted upregulation of multiple
genes associated with mitochondria and oxidative phosphorylation
in reset cells cultured on laminin and on feeders (Fig. S3A-C),
consistent with metabolic reprogramming between primed and
naïve pluripotency (Takashima et al., 2014; Zhou et al., 2012).
Overall, cR cells share global gene expression features with ICM-
derived HNES cells and transgene-reset PSCs and are distinct from
various primed PSCs. Genes highly upregulated in naïve conditions
relative to conventional PSCs are highlighted in Fig. 4C.
Table 1. Karyotype analyses of reset cultures
Parental line; passage (P)
at resetting Substrate*, passages‡ Karyotype§ Identifier
ESCs Shef6EOS; P18 MEF, P16, Y 46,XX [20] cR-S6VPCY
″ ″ MEF, P40, Y 46,XX,add(19)(q13) [30]
Shef6EOS; P26 MEF, P7, Y 46,XX [30] cR-S6EOS-Y
Shef6EOS; P26 MEF, P7 46,XX [30] cR-S6EOS
Shef6; P37 MEF, P3; +LN, P14 46,XX [15]/46,XX,add(6)(q2) [5]
″ ″ MEF, P3; +LN, P14; +GT, P9 46,XX [30]
H9EOS; P43 MEF, P8, Y 46,XX [28]/46,XX,del(3)(p21) [2] cR-H9EOS-Y
H9EOS; P43 MEF, P8 46,XX [30] cR-H9EOS
H9EOS; P43¶ MEF, P8, Y 46,XX [24]/46,XX,del(3)(p21) [6]
iPSCs Fips; P53 MEF, P7 46,XX [30] cR-Fips
Fips; P53 MEF, P7, Y 46,XX [23]/47,XX,+20 [7] cR-Fips-Y
NCRM2; P29¶ MEF, P7 46,XX [26/30]# cR-NCRM2
″ ″ MEF, P18 46,XX [10]/48,XX+11,+16 [5]
″ ″ MEF, P5; +LN, P5 46,XX [30]
″ ″ MEF, P5; +GT, P16 46,XX [30]
*MEF, mouse embryonic fibroblast feeders; LN, laminin; GT, Geltrex.
‡Y indicates culture maintained in medium containing Y27632.
§Numbers in square brackets are the number of spreads with the indicated karyotype.
¶Reset with sodium butyrate.
#Four different abnormalities, each detected in a single metaphase.
Semi-colons mark transfers in culture conditions during continuous propagation of reset cells.
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We inspected the expression of transposable elements (TEs) – the
transposcriptome (Friedli and Trono, 2015). A number of TEs are
known to be transcriptionally active in early embryos and PSCs,
potentially with functional significance. PCA of TE expression
separated cR and HNES cells from primed PSCs (Fig. S3D,E).
Notably, HERVK, SINE-VNTR-Alu (SVA) and LTR5_Hs
elements were upregulated in naïve cultures (Fig. 4D). Inspection
of KRAB-ZNFs, potential regulators of TE expression, revealed that
many are significantly upregulated in reset cells (Fig. S3F). These
include ZNF229 and ZNF534, which represses HERVH elements
(Theunissen et al., 2016), ZNF98 and ZNF99, which are also
upregulated during epigenetic resetting of germ cells (Tang et al.,
2015), and ZFP57, which protects imprints in the mouse
(Quenneville et al., 2011).
We compared relative transcript levels for a panel of pluripotency
markers between cR cells and human pre-implantation embryos. For
the embryo data we used published single-cell RNA-seq (Blakeley
et al., 2015; Yan et al., 2013). Normalised expression was consistent
between reset cells and the epiblast, more so than with earlier
stage embryonic cells (Fig. 4E). Primed PSCs exhibited no or low
Fig. 2. Feeder-free culture. (A) Cells plated on Geltrex-coated plates (left) or with Geltrex added to the medium (right). Images taken after 4 days. (B) Cultures in
Geltrex (GT) or laminin (LN) for more than ten passages. (C) Immunostaining for pluripotency markers in reset cells passaged in laminin. (D) Naïve marker
expression in feeder-free reset cultures in t2iLGö as determined by RT-qPCR and normalised to the expression level in H9-NK2 transgene reset cells. (E) Lineage
marker expression in feeder-free reset cultures relative to levels on feeders. (F) Reset cells plated in the presence of the indicated concentrations (µM)
of the GSK3 inhibitor CHIR99021 (CH) for 4 days. (G) Images of colony expansion over 4 days in Geltrex. (H) Growth curve for reset cells in tt2ilGö and Geltrex.
Error bars indicate s.d. from triplicate cultures. (I) RT-qPCR marker profile for cells reset with or without CH and expanded in tt2iLGö and Geltrex, normalized to
expression level in cR-H9 cells on MEF in tt2iLGö. Error bars on PCR plots indicate s.d. of technical duplicates. Scale bars: 100 μm in A,B,F,G; 50 μm in C.
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Fig. 3.WNT inhibition stabilises resetting. (A) Alkaline phosphatase staining of H9-NK2 colonies at first and second passage after DOXwithdrawal and transfer
into t2iLGö alone or plus L-proline (L-Pro) or the tankyrase inhibitor XAV939 (XAV). (B) RT-qPCR analysis of marker expression in H9-NK2 cells at passage 2,
treated as in A. KSR/FGF reference sample is a conventional S6EOS culture. (C) Resetting protocol with WNT inhibitors. (D) (Top) Flow analysis of
resetting H9EOS cells cultured in the presence or absence of WNT inhibitors. (Bottom) Flow analysis after two passages (a further 8 days) in tt2iLGö with WNT
inhibitors on MEFs. (E) cR-H9EOS colonies in tt2iLGö with XAV or the WNT pathway inhibitor IWP2 after two passages on MEFs. (F) Marker analysis by
RT-qPCR for cR-H9EOS cells at passage 2 cultured in tt2iLGö with and without WNT inhibitors. (G) Marker analysis by RT-qPCR of cR-H9EOS cultures
generated with or without XAV and transferred into tt2iLGö on Geltrex (without XAV) for four passages. Error bars on PCR plots indicate s.d. of technical
duplicates. Scale bars: 200 μm in A; 100 μm in E.
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Fig. 4. Transcriptome analysis of reset PSCs. (A) Principal component analysis (PCA) of whole-transcriptome RNA-seq data from the indicated cell lines.
(B) t-SNE analysis of RNA-seq data. (C) Heatmap of differentially expressed genes between chemically reset (cR) and embryo-derived HNES cells (naïve)
compared with conventional hPSCs (primed). Genes unregulated in naïve cells are shown, ranked by log2 fold-change (FC). Values displayed correspond to
the average expression level in each sample group scaled by the mean expression of each gene. (D) Heatmap showing expression of all transposon families that
are differentially expressed (log2 FC>1.5, P<0.05). (E) Comparative expression of pluripotency markers in human embryo cells (Blakeley et al., 2015; Yan et al.,
2013), HNES cells, cR cells, conventional primed PSCs, NHSM cultures and purported expanded potency (EPS) cells. Data shown reflect mean expression
levels from cell lines and biological replicates belonging to each sample group, and single cells from indicated embryo stages. Published datasets used are
identified in the Materials and Methods.
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expression of several of these key markers. A set of genes
upregulated in reset cells were also expressed in the human ICM and
epiblast, and their expressionwas low or absent in various conventional
and alternative primed PSC cultures (Fig. 4E, Fig. S4). These genes
encode transcription factors, epigenetic regulators, metabolic
components and surface proteins, and provide several candidate
markers of human naïve pluripotency. In addition, we inspected
recently published transcriptome data from cynomolgus monkey
embryos (Nakamura et al., 2016). Analysis of the most differentially
expressed genes between reset and primed PSCs separated the
cynomolgus samples into two clusters (Fig. S5). Notably, reset cells
share features with the pre-implantation epiblast, whereas primed PSCs
are more similar to pre-streak and gastrulating epiblast.
Methylome status
Global DNA hypomethylation is a distinctive characteristic of
mouse and human ICM cells (Guo et al., 2014; Lee et al., 2014;
Smith et al., 2012) that is manifest in candidate naïve hPSCs
(Takashima et al., 2014; Theunissen et al., 2016). We performed
whole-genome bisulfite sequencing (BS-seq) on primed S6EOS
and on reset S6EOS and H9 EOS cultures derived from independent
experiments with or without addition of XAV. Methylation profiles
were compared with previous datasets for primed PSCs, human
ICM cells (Guo et al., 2014), transgene reset PSCs (H9-NK2;
Takashima et al., 2014) and HNES1 cells (Guo et al., 2016). Primed
PSCs show uniformly high levels of DNA methylation (85-95%),
whereas reset cells display globally reduced CpG methylation,
comparable to ICM and with a similar relatively broad distribution
(Fig. 5A). Hypomethylation extended over all genomic elements
(Fig. S6B) and was lower in cells that had been through more than
ten passages in t2iLGö. Loss of methylation from primed to reset
conditions was not uniform across the whole genome, however.
Highly methylated (80-100% methyl-CpG) regions in primed cells
showed divergent demethylation to between 15% and 65% methyl-
CpG (Fig. 5A,B, Fig. S6C). The majority of promoters were
methylated at low levels in both primed and reset S6EOS cells
(Fig. 5C), including most CpG island (CGI)-containing promoters.
Among methylated promoters in primed PSCs, many showed
decreased methylation in reset cells in line with the global trend.
However, we also identified a number of CGI and non-CGI
promoters that gainedmethylation upon resetting (highlighted in red
in Fig. 5C; >40% CpG methylation difference between primed and
averaged reset cells). GO analysis of the genes associated with this
group of promoters indicated enrichment for terms related to
differentiation, development and morphogenesis (Fig. S6D).
Transgene reset and HNES1 cells also showed significantly
higher promoter methylation levels at these loci than their primed
counterparts (Fig. 5D), suggesting that selective promoter
methylation is a feature of naïve-like cells in t2iLGö. By contrast,
we observed that many, although not all, imprinted differentially
methylated regions (DMRs) are demethylated in reset conditions
(Fig. 5E), in line with previous findings (Pastor et al., 2016).
The correlation between gene expression and promoter
methylation (Fig. 5F, Fig. S6E) is very weak overall, as
previously noted in mouse ESCs (Ficz et al., 2013; Habibi et al.,
2013). Nonetheless, some genes that are highly upregulated in reset
cells and potentially functionally significant, such as KLF17,
DNMT3L and ZNF534, show striking reductions in promoter
methylation. Conversely, although TEs in general obeyed the
genome-wide trend of hypomethylation in reset cells, substantial
subsets of the HERVH and LTR7 TE families gained methylation
and most of these showed reduced expression or were silenced
(Fig. 5G). Finally, we noted demethylation of the piggyBac repeat
sequences in cR-S6EOS cells (Fig. S6F), consistent with the
proposition that the transgene is subject to epigenetic repression in
primed cells that is relieved by resetting.
Chromosomal stability
A major concern with manipulation of PSC culture conditions is the
potential for selection of genetic variants (Amps et al., 2011). Indeed, it
has previously been noted that naïve-like cells cultured in the 5i/L/A
formulation are prone to aneuploidy (Pastor et al., 2016; Sahakyan et al.,
2017; Theunissen et al., 2014). We therefore carried out metaphase
chromosome analyses by G-banding on a selection of cR cells
(Fig. S2E). The results presented in Table 1 show retention of a
diploid karyotype in most cases, although in some cultures minor
subpopulations of aneuploid cells are present. These data indicate that
the epigenetic resetting process does not induce major chromosomal
instability nor select for pre-existing variants, in line with previous
observations that cultures in t2iLGö can maintain a diploid karyotype
(Guo et al., 2016; Takashima et al., 2014). However, we noticed a
variable incidence of tetraploid cells during expansion and one line
showed a ubiquitous gain of chr19q13 after extended culture (40
passages). cR and HNES1 cells could also maintain a diploid karyotype
over multiple passages in Geltrex or laminin, although abnormalities
emerged in some cultures (Table 1). We also examined the
transcriptome data by variant analysis for mutations in TP53 that have
been detected recurrently in primed PSCs (Merkle et al., 2017). None of
the loss-of-function TP53 mutations identified was found in cR cells.
Differentiation
To assess the multi-lineage potential of cR cells we first used
embryoid body differentiation. After 3 days of floating culture in t2iL
without Gö, aggregates were transferred to Geltrex-coated dishes and
differentiated as outgrowths in serum. Alternatively, reset cells were
transferred into E8 medium for 6 days then aggregated in serum for
3 days before outgrowth. RT-qPCR on 8 day outgrowths showed
upregulation in both conditions of markers of early neuroectoderm,
mesoderm and endoderm specification (Fig. S7A). Induction of these
markers was lower for reset cells taken directly from t2iLGö than for
cells conditioned in E8 (Fig. S7A), whereas downregulation of
pluripotency markers was similar in both cell types. Immunostaining
evidenced expression of protein markers of mesoderm and endoderm
differentiation (Fig. S7B) and, at lower frequency, of neuron-specific
β-tubulin.
We then evaluated directed lineage commitment in adherent
culture. Unsurprisingly, cR cells taken directly from t2iLGö did not
respond directly to definitive endoderm or neuroectoderm induction
protocols (Chambers et al., 2009; Loh et al., 2014) developed for
primed PSCs (Fig. S7C). After prior transfer into N2B27 for 3 days,
a CXCR4/SOX17-positive, PDGFRα-negative population,
indicative of definitive endoderm, could be obtained (Fig. S7D)
but neural marker induction in response to dual SMAD inhibition
remained low. We therefore converted cR cells into a conventional
primed PSC state by culture in E8 medium on Geltrex for several
passages (Fig. S7E). We then applied the protocols for germ layer
specification from primed cells to three different ʻre-primed’
cultures. We observed robust expression of lineage markers for
endoderm, lateral plate mesoderm and neuroectoderm by RT-qPCR
(Fig. 6A). Immunostaining for SOX17 and FOXA2, and for SOX1
and PAX6, validated the widespread generation of endoderm or
neuroectoderm, respectively (Fig. 6B). Flow cytometric analysis
quantified efficient induction of all three lineages (Fig. 6C,
Fig. S7F). We examined further neuronal differentiation. After
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29 days we detected expression of neuronal markers by RT-qPCR
(Fig. 6D). Many cells with neurite-like processes were
immunopositive for MAP2 and NEUN (RBFOX3) (Fig. 6E). By
40 days, markers of maturing neurons were apparent: vesicular
glutamate transporter (vGlut2; SLC17A6), the post-synaptic protein
SNAP25 and the presynaptic protein bassoon (Fig. 6F).
We also subjected cR-S6EOS cells to a protocol for
inducing primordial germ cell-like cells (PGCLCs). Cells were
transferred from t2iLGö into TGFβ and FGF for 5 days,
followed by exposure to germ cell-inductive cytokines (Irie
et al., 2015; von Meyenn et al., 2016). Cells co-expressing
tissue non-specific alkaline phosphatase and EOS-GFP,
suggestive of germ cell identity, were isolated by flow cytometry
on day 9. Analysis of this double-positive population by RT-qPCR
showed upregulated expression of a panel of primordial germ
cell markers (Fig. S7G). These data indicate that germ cell
Fig. 5. Methylome analysis of reset PSCs. (A) Bean plots showing the global distribution of CpG methylation levels from pooled replicates of the indicated
samples compared with human ICM data (Guo, 2014). Reset samples are from independent derivations without or with addition of XAV. Methylation was
quantitated over 20 kb genomic tiles. Note that KCL37 and HNES1 are male and H9 and Shef6 are female. (B) Scatter plots of CpG methylation percentages
over tiles spanning 20 kb on chromosome 7 and chromosome X, comparing parental Shef6EOS (in KSR/FGF) with cR-S6EOS. (C) Scatter plots of CpG
methylation over promoters (−900 to +100), for parental and cR-S6EOS cells. Promoters with >40% gain in CpG methylation in reset cells are highlighted in red.
(D) CpG methylation levels of a subset of promoters highlighted (red) in C in the indicated samples. (E) Averaged CpG methylation of known DMRs of
imprinted maternal and paternal genes. Sperm and oocyte data are from Okae et al. (2014); ICM from Guo et al. (2014); H9 and H9-NK2 from Takashima et al.
(2014). (F) Scatter plot showing the change in expression (log2 FC) against the difference in promoter methylation for reset (averaged over cR-H9EOS and
cR-S6EOS) versus parental Shef6EOS. (G) Scatter plots for prominent differentially expressed transposon families showing the change in expression (log2 FC)
versus the difference in methylation for all loci.
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specification may be induced from chemically reset cells, as also
shown for reset cells generated by transgene expression (von
Meyenn et al., 2016).
X-chromosome activity
Female naïve cells are expected to have two active X chromosomes
in human, as in mouse. Unlike in mouse, however, XIST is
Fig. 6. Differentiation of reset PSCs. (A) RT-qPCR analysis of lineage specification markers after induction of re-primed cR lines. ‘Non’ indicates non-induced;
Ecto, neuroectoderm; DE, definitive endoderm; LPM, lateral plate mesoderm. (B) Immunostaining for lineage specification markers. (C) Summary of flow
cytometric quantification of neuroectodermal, mesodermal and endodermal lineage specification. (D) RT-qPCR assays for pan-neuronal markers after 29 days
differentiation from re-primed cR-S6EOS cells. (E) Immunostaining for neuronal markers MAP2 and NEUN after 29 days. (F) Immunostaining for neuronal
maturation markers after 40 days. Arrowheads (middle) highlight expected punctate clusters of SNAP25; arrows (right) indicate a non-stained cell to show
antibody specificity. Error bars in PCR plots are s.d. of technical duplicates. Scale bars: 100 µm in B,E; 10 µm in F.
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expressed from one or both active X chromosomes in human ICM
cells (Okamoto et al., 2011; Petropoulos et al., 2016; Vallot et al.,
2017) as well as from the inactive X in differentiated cells. Primed
female hPSCs usually feature an inactive X, although this has
frequently lost XIST expression, a process referred to as erosion
(Mekhoubad et al., 2012; Silva et al., 2008). X chromosomes in
female cR-S6EOS cells showmore marked loss of methylation than
autosomes (Fig. S6C), suggestive of reactivation (Takashima et al.,
2014). We employed RNA FISH to assess nascent transcription
fromX chromosomes at the single-cell level. In parental S6EOS and
H9EOS cells the presence of two X chromosomes was confirmed by
RNA FISH for XACT (Fig. S8A), which is transcribed from both
active and eroded X chromosomes (Patel et al., 2017; Vallot et al.,
2017). No XIST signal was evident in either cell line but we detected
monoallelic transcription of HUWE1, an X-linked gene typically
subject toX-chromosome inactivation (Patel et al., 2017) (Fig. 7A,B).
By contrast, reset cells displayed biallelic transcription of HUWE1
in the majority (90%) of diploid cells for both lines. Similar results
were obtained for two other X-linked genes: ATRX and THOC2
(Fig. S8A,B). XISTwas detected monoallelically in a subset of reset
cells (Fig. 7A,B). This unusual feature is in line with recent reports
that human naïve-like cells have two active X chromosomes, but
predominantly express XIST from neither, or only one, allele
(Sahakyan et al., 2017; Vallot et al., 2017).
We also examined X-chromosome status after reset cells had been
reverted to a primed-like PSC state by culture in E8 medium for
30 days as above. We found that HUWE1 became transcribed
monoallelically in ∼90% of ʻre-primed’ cR-S6EOS cells and that
almost all of those cells expressed XIST from the other X
chromosome (Fig. 7A,B). For cR-H9EOS, 40% of re-primed cells
showed monoallelic expression of HUWE1, and those cells also
upregulated XIST from the other, inactive X chromosome. Similar
patterns were observed when we co-stained the cells for XIST and
another X-linked gene, THOC2 (Fig. S8A). These data are
consistent with induction of X-chromosome silencing by XIST
during pluripotency progression.
DISCUSSION
The availability of candidate naïve hPSCs offers an experimental
system for investigation of human pluripotency progression and a
potentially valuable source material for biomedical applications. Our
findings demonstrate that cell populations exhibiting a range
of properties consistent with naïve pluripotency can readily be
generated from primed PSCs by transient HDAC inhibition followed
by culture in t2iLGö or tt2iLGö. WNT inhibition stabilises initial
acquisition of the reset phenotype. Chemically reset cells are
phenotypically stable and in many cases cytogenetically normal.
They can be propagated robustly without feeders and readily be re-
primed to undergo multi-lineage differentiation in vitro. We provide
detailed protocols alongwith global transcriptome, transposcriptome
and methylome datasets as resources for the community.
The mechanism by which HDAC inhibition promotes resetting is
unresolved but seems likely to involve the generation of a more open
chromatin environment that relieves silencing of naïve pluripotency
factors. The reset phenotype is initially rather precarious but can be
stabilised by inhibitors of tankyrase or porcupine that suppress the
canonical WNT pathway. cR cells differ dramatically in global
expression profile from primed PSCs and resemble previously
described human naïve-like cells generated by inducible or transient
transgene expression (Takashima et al., 2014) or by adaptation to
culture in 5i/L/A/(F) (Theunissen et al., 2014). In particular,
transcriptome analysis shows that cR cells share a high degree of
genome-wide and marker-specific correspondence with HNES cell
lines derived directly from dissociated human ICM (Guo et al.,
2016). Reset cells express transcription regulators and other genes
that are found in human pre-implantation epiblast but are low or
absent in primed PSCs. These include the characterised naïve
pluripotency factors KLF4 and TFCP2L1, along with potential new
regulators and markers.
Reset and HNES cells express SVA, LTR5, HERVK and SST1
TEs. These are among the most recent entrants to the human
genome and are transcribed in pre-implantation embryos (Grow
et al., 2015; Theunissen et al., 2016). By contrast, HERVH families
and their flanking LTR7 repeats are mostly downregulated in reset
cells and exhibit increased methylation. These findings confirm and
extend the recent report that specific TE expression discriminates
between primed and naïve-like hPSCs (Theunissen et al., 2016).
HERVH and LTR7 are reported to generate alternative and
chimaeric transcripts in primed PSCs, where they display
heterogeneous expression (Wang et al., 2014). Therefore,
silencing in naïve cells and derepression upon progression to
primed pluripotency might have functional significance. Notably,
ZNF534, the postulated negative regulator of HERVH (Theunissen
et al., 2016), is highly upregulated in reset cells, while increased
expression of DNMT3L in human naïve-like cells, a feature not
apparent in mouse ESCs, may facilitate de novo methylation at
specific TE loci.
During resetting, DNA methylation is globally reduced to a level
similar to that reported for human ICM (Guo et al., 2014). This is
regarded as a key process for erasure of epigenetic memory in the
naïve phase of pluripotency (Lee et al., 2014). Reduced methylation
extends to all classes of genomic element but is non-uniform. At
promoters, both loss and gain of methylation are detected. As in
other cell types, there is poor overall correlation with gene
expression but it is noteworthy that extensively demethylated
promoters in reset cells include several associated with highly
upregulated genes that are likely to be functional in naïve cells,
including KLF17, as well as numerous primate- and hominid-
specific TEs. Demethylation also extends to imprinted loci,
however, as noted previously for other human naïve-like stem
cells (Pastor et al., 2016; Theunissen et al., 2016). Loss of imprints
is observed in conventional hPSCs (Nazor et al., 2012) and in
mouse ESCs (Dean et al., 1998; Greenberg and Bourc’his, 2015;
Walter et al., 2016), but not typically to the extent detected for
human naïve-like cells. Whether failure to sustain imprints is an
intrinsic feature of human naïve pluripotency during extended
propagation or may be rectified by modification of the culture
environment remains to be determined.
Efficient multi-lineage differentiation may be initiated from reset
cells either via embryoid body formation or by ʻre-priming’ in
adherent culture. It is noteworthy, however, that human cells in the
t2iLGö naïve condition are not immediately responsive to lineage
induction. Ground-state mouse ESCs also appear not to respond
directly to lineage cues but to require prior transition through a
formative stage (Kalkan et al., 2017; Mulas et al., 2017; Semrau
et al., 2016 preprint). This capacitation period might be more
protracted in primates given the longer window between
implantation and gastrulation (Nakamura et al., 2016; Smith, 2017).
A hallmark of the transient phase of naïve pluripotency in both
rodent and human ICM cells is the presence of two active X
chromosomes in females (Okamoto et al., 2011; Petropoulos et al.,
2016; Sahakyan et al., 2017; Vallot et al., 2017). In female cR
cells, the gain of biallelic expression of X-linked genes indicates
reactivation of the silent X chromosome. Moreover, expression of
2758
STEM CELLS AND REGENERATION Development (2017) 144, 2748-2763 doi:10.1242/dev.146811
D
E
V
E
LO
P
M
E
N
T
XIST from an active X chromosome in a subset of reset cells
resembles the pattern of the human pre-implantation embryo. Upon
re-priming, monoallelic expression of X-linked genes is restored in
many cells. Significantly, although no XIST was observed in the
original primed cells, an XIST signal is detected in re-primed
cells on a silenced X chromosome. Resetting and subsequent
differentiation thus offer a system to characterise X-chromosome
regulation in human, which appears to diverge substantially from
the mouse paradigm (Okamoto et al., 2011).
In summary, this study provides the requisite technical protocols
and resources to facilitate routine generation and study of candidate
human naïve PSCs. Moreover, feeder-free culture simplifies the
propagation of reset cells. Nonetheless, further refinements are
desirable to enhance the quality and robustness of naïve hPSCs,
including preserving imprints and maximising long-term karyotype
stability. Optimising the capacitation process prior to differentiation
by recapitulating the progression of pluripotency in the primate
embryo is an important future goal and opportunity.
Fig. 7. X-chromosome status of parental, reset and re-primed cells. (A) S6EOS. (B) H9EOS. Images showRNA FISH for nascent X-linked RNA transcription.
Note that in re-primed cells displaying monoallelicHUWE1 and XIST expression, the two signals are on different chromosomes. Bar charts show quantification of
X-chromosome activation status based on HUWE1 and XIST signals from samples of at least 100 cells.
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MATERIALS AND METHODS
Conventional hPSC culture
Primed hPSCs were routinely maintained on irradiated mouse embryonic
fibroblast (MEF) feeder cells in KSR/FGF medium: DMEM/F-12 (Sigma-
Aldrich, D6421) supplemented with 10 ng/ml FGF2 (prepared in-house),
20% KnockOut Serum Replacement (KSR) (Thermo Fisher Scientific),
100 mM 2-mercaptoethanol (2ME) (Sigma-Aldrich, M7522), 1×MEM
non-essential amino acids (NEAA) (Thermo Fisher Scientific, 11140050)
and 2 mM L-glutamine (Thermo Fisher Scientific, 25030024). Cells were
passaged as clusters by detachment with dispase (Sigma-Aldrich,
11097113001). To establish PB-EOS stable transfectants, 1 μg/ml
puromycin was applied for two passages (10 days) to transfected cells on
Matrigel (Roche). Some PSC lines were propagated without feeders on
Geltrex (growth factor-reduced, Thermo Fisher, A1413302) in E8 medium
[made in-house according to Chen et al. (2011)].
Naïve cell culture
Chemically reset and embryo-derived (HNES) naïve stem cells were propagated
in N2B27 (see the supplementary Materials and Methods) supplemented with
t2iLGö [1 µMCHIR99021 (CH), 1 µMPDO325901 (PD), 10 ng/ml humanLIF
and 2 µM Gö6983] with or without ROCK inhibitor (Y-27632) on irradiated
MEF feeders. Where indicated as tt2iLGö, CH was used at 0.3 µM. For feeder-
free culture, Geltrex or laminin (Merck, CC095) was added to the medium at the
time of plating. Cells were cultured in 5%O2, 7%CO2 in a humidified incubator
at 37°C and passaged by dissociation with Accutase (Thermo Fisher Scientific,
A1110501) or TrypLE (Thermo Fisher Scientific, 12605028) every 3-5 days.
Cells were cryopreserved in CryoStem (Biological Industries, K1-0640). Cell
lines were tested free of mycoplasma contamination in-house by PCR. No other
contamination test has been performed.
Reverse transcription and real-time PCR
Total RNAwas extracted using anRNeasyKit (Qiagen) and cDNA synthesized
with SuperScript III reverse transcriptase (Thermo Fisher Scientific, 18080085)
and oligo(dT) adapter primers. TaqMan assays and Universal ProbeLibrary
(UPL) probes (RocheMolecular Systems) are listed in Table S3A,B. Embryoid
bodies were lysed in TRIzol (Thermo Fisher Scientific, 15596018) and total
RNA was isolated with PureLink RNA Mini Kit (Thermo Fisher Scientific,
12183025) with On-Column PureLink DNase (Thermo Fisher Scientific,
12185010). For analyses of adherent differentiation, total RNA was extracted
with ReliaPrep RNA Miniprep Kit and RT-qPCR performed using oligo(dT)
primer, the GoScript Reverse Transcription System and GoTaq qPCR Master
Mix (all from Promega).
Immunostaining
Cells were fixed with 4% buffered paraformaldehyde for 15 min at room
temperature, permeabilised with 0.5% Triton X-100 in PBS for 10 min and
blocked with 3% BSA and 0.1% Tween 20 in PBS for 30 min at room
temperature. Incubation with primary antibodies (Table S3C) diluted in PBS
with 0.1% Triton X-100 and 3% donkey serum was overnight at 4°C and
secondary antibodies were added for 1 h at room temperature. Slides were
mounted with Prolong Diamond Antifade Mountant (Life Technologies).
Chromosome analysis
G-banded karyotype analysis was performed following standard
cytogenetics protocols, typically scoring 30 metaphases.
Transcriptome sequencing
Total RNA was extracted using the TRIzol/chloroform method (Invitrogen)
and RNA integrity assessed using a Qubit 2.0 fluorometer (Thermo Fisher
Scientific) and RNANanoChip Bioanalyzer (Agilent Genomics). Ribosomal
RNA was depleted from 1 µg total RNA using Ribo-Zero (Illumina).
Sequencing libraries were prepared using the NEXTflex Rapid Directional
RNA-Seq Kit (Bioo Scientific, 5138-08). Sequencing was performed on an
Illumina HiSeq4000 in either single-end 50 bp or paired-end 125 bp format.
RNA-seq data analysis
External datasets used for comparative analyses were obtained from the
European Nucleotide Archive (ENA) under accessions ERP006823
(Takashima et al., 2014), SRP059279 (Ji et al., 2016), SRP045911
(Sperber et al., 2015), SRP045294 (Irie et al., 2015), SRP011546 (Yan et al.,
2013), SRP055810 (Blakeley et al., 2015), SRP074076 (Yang et al., 2017)
and ERP007180 (Wellcome Trust Sanger Institute). To minimise technical
variability, reads of disparate lengths and sequencing modes were truncated
to 50 bp single-end format. Alignments to human genome build hg38/
GRCh38 were performed with STAR (Dobin et al., 2013). Transcript
quantification was performed with htseq-count, part of the HTSeq package
(Anders et al., 2014), using gene annotation from Ensembl release 86 (Aken
et al., 2016). Libraries were corrected for total read count using the size
factors computed by the Bioconductor package DESeq2 (Love et al., 2014).
Principal components were computed by singular value decomposition with
the prcomp function in the R statistics package from variance-stabilised
count data. Differential expression was computed with DESeq2 and genes
ranked by log2 fold-change. t-distributed stochastic neighbour embedding
(t-SNE) (van der Maaten and Hinton, 2008) was performed using the
Barnes-Hut algorithm (Van Der Maaten, 2014) implemented in the
Bioconductor package Rtsne with perplexity 12 for 1600 iterations. For
display of expression values, single-end count datawere normalised for gene
length to yield RPKMs and scaled relative to the mean expression of each
gene across all samples. Heatmaps include genes for which a difference in
expression was observed (i.e. scaled expression >1 or <−1 in at least one
sample). For functional testing, enrichment for GO terms was determined
using the GOStats package (Falcon and Gentleman, 2007) based on the
1000 most upregulated and downregulated genes distinguishing naïve
and primed cells, and most significant genes contributing to principal
component 1 (Fig. 3A). RNA-seq libraries were screened for mutations
in the P53 locus by processing alignments with Picard tools (http://
broadinstitute.github.io/picard) and the Genome Analysis Toolkit (GATK)
(DePristo et al., 2011; McKenna et al., 2010) to filter duplicate reads,
perform base quality score recalibration, identify indels for realignment, and
call variants against dbSNP build 150 (Sherry et al., 2001).
Bisulfite sequencing, mapping and analysis
Post-bisulfite adaptor tagging (PBAT) libraries for whole-genome DNA
methylation analysis were prepared from purified genomic DNA (Miura
et al., 2012; Smallwood et al., 2014; von Meyenn et al., 2016). Paired-end
sequencing was carried out on HiSeq2000 or NextSeq500 instruments
(Illumina). Raw sequence reads were trimmed to remove poor quality reads
and adapter contamination using Trim Galore (v0.4.1) (Babraham
Bioinformatics). The remaining sequences were mapped using Bismark
(v0.14.4) (Krueger and Andrews, 2011) to the human reference genome
GRCh37 in paired-end mode as described (von Meyenn et al., 2016). CpG
methylation calls were analysed using SeqMonk software (Babraham
Bioinformatics) and custom R scripts. Global CpG methylation levels of
pooled replicates were illustrated using bean plots. The genomewas divided
into consecutive 20 kb tiles and percentage methylation was calculated
using the bisulfite feature methylation pipeline in SeqMonk. Pseudocolour
scatter plots of methylation levels over 20 kb tiles were generated using R.
Specific genome features were defined using the following Ensembl gene
sets annotations: Gene bodies (probes overlapping genes), Promoters (probes
overlapping 900 bp upstream to 100 bp downstream of genes), CGI promoters
(promoters containing a CGI), non-CGI promoters (all other promoters),
Intergenic (probes not overlapping with gene bodies), non-promoter CGI (CGI
not overlapping with promoters). Annotations of human germline imprint
control regions were obtained fromCourt et al. (2014). Pseudocolour heatmaps
representing average methylation levels were generated using the R heatmap.2
function without further clustering, scaling or normalisation. Correlation
between promoter methylation and gene expression was computed from
average CpGmethylation across promoters or TEs and correlating these values
with the respective gene expression values.
Fluorescent in situ hybridisation (FISH)
Nascent transcription foci of X-linked genes and the lncRNAs XIST and
XACT were visualised at single-cell resolution by RNA FISH as described
(Sahakyan et al., 2017). Fluorescently labelled probes were generated from
BACs RP11-13M9 (XIST), RP11-35D3 (XACT), RP11-121P4 (THOC2),
RP11-1145J4 (ATRX) and RP11-975N19 (HUWE1). Coverslips were
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imaged using an Imager M1 microscope (Zeiss) and AxioVision software.
ImageJ was used for collapsing z-stacks, merging different channels, and
adjusting brightness and contrast to remove background. Aminimum of 100
nuclei were scored for each sample. Cells that appeared to have more than
two X chromosomes were excluded.
Transposable elements
RepeatMasker annotations for the human reference genomewere obtained from
the UCSC Table Browser. To calculate repeat expression, adapter-trimmed
RNA-seq readsweremapped to the reference genome using bowtie (Langmead
and Salzberg, 2012) with parameters ‘−M1 –v2 –best –strata’, i.e. two
mismatches were allowed, and one alignment location was randomly selected
for reads that multiply align to the reference genome. Read counts for repeat
regions and Ensembl transcripts were calculated by featureCounts, normalised
by the total number of RNA-seq reads that mapped to protein-coding gene
regions. Differential expression of repeat copies across samples was evaluated
by the R Bioconductor DESeq package (Anders and Huber, 2010).
Embryoid body differentiation
Embryoid body formation and outgrowth were performed in DMEM/F12
supplemented with 15% fetal calf serum (FCS), 2 mM L-glutamine. 1 mM
sodium pyruvate, 1× non-essential amino acids and 0.1 mM 2ME as
described (Guo et al., 2016). Alternatively, reset cells were aggregated in
t2iLIF medium with ROCK inhibitor in PrimeSurface 96V cell plates
(Sumitomo Bakelite MS-9096V) then plated after 3 days on Geltrex
(Thermo Fisher Scientific, 12063569) for outgrowth in serum-containing
medium. Outgrowths were fixed with 4% paraformaldehyde for 10 min at
room temperature for immunostaining.
Adherent differentiation
Except where specified, reset cells were ʻre-primed’ before initiating
differentiation. Cells were plated on Geltrex in t2iLGö and after 48 h the
medium was changed to E8. Cultures were maintained in E8, passaging at
confluence. Lineage-specific differentiation was initiated between 25 and
44 days.
Definitive endoderm was induced according to Loh et al. (2014). Cells
were cultured in CDM2 medium (in-house according to Loh et al., 2014)
supplemented with 100 ng/ml activin A (produced in-house), 100 nM PI-
103 (Bio-Techne, 2930), 3 µM CHIR99021, 10 ng/ml FGF2, 3 ng/ml
BMP4 (Peprotech) for 1 day. For the next 2 days the following supplements
were applied: 100 ng/ml activin A, 100 nM PI-103, 20 ng/ml FGF2,
250 nM LDN193189.
For lateral mesoderm induction (Loh et al., 2016), cells were treated with
CDM2 supplemented with 30 ng/ml activin A, 40 ng/ml BMP4 (Miltenyi
Biotech, 130-098-788), 6 µMCHIR99021, 20 ng/ml FGF2, 100 nM PI-103
for 1 day, then with 1 µM A8301, 30 ng/ml BMP4 and 10 µM XAV939
(Sigma-Aldrich).
For neural differentiation via dual SMAD inhibition (Chambers et al.,
2009), cells were treated with N2B27 medium supplemented with 500 nM
LDN193189 (Axon, 1509) and 1 μM A 83-01 (Bio-Techne, 2939) for
10 days, then passaged to plates coated with poly-L-ornithine and laminin
and further cultured in N2B27 without supplements.
Flow cytometry
Flow analysis was carried out on a Fortessa instrument (BD Biosciences). Cell
sortingwas performed using aMoFlo high-speed instrument (BeckmanCoulter).
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